Development and Validation of Safety of a New Antimicrobial Agent Therapy to early healing for Individual Periodontal Disease
Not Applicable
Completed
- Conditions
- Periodontitis
- Registration Number
- JPRN-UMIN000012033
- Lead Sponsor
- Department of Periodontology, Tsurumi University School of Dental Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with any systemic illness known to affect the outcomes of periodontal treatment 2) Pregnancy and/or lactation 3) Smoker 4) Other(Doctors dicision)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Primary Outcome of this Study is to Evaluate the Efficacy for New Antimicrobial Agent Therapy for Periodontal Disease Patient.
- Secondary Outcome Measures
Name Time Method The Secondary Outcome of this Study is to Evaluate the Safety for New Antimicrobial Agent Therapy for Periodontal Disease Patient.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular targets does the systemic antimicrobial agent in JPRN-UMIN000012033 modulate for periodontitis treatment?
How does the new antimicrobial therapy in JPRN-UMIN000012033 compare to metronidazole in periodontitis clinical outcomes?
Which biomarkers correlate with therapeutic response to systemic antimicrobial agents in JPRN-UMIN000012033 periodontitis trials?
What are the safety profiles and adverse event management strategies for systemic antimicrobial agents in JPRN-UMIN000012033?
What combination therapies or competitor drugs show promise in periodontitis treatment alongside JPRN-UMIN000012033's approach?